Literature DB >> 10865558

Pregnancy outcome after previous stillbirth resulting from causes other than maternal conditions and fetal abnormalities.

S Heinonen1, P Kirkinen.   

Abstract

BACKGROUND: An adequate fetomaternal circulatory system may be compromised by a variety of disturbances leading to stillbirth. The purpose of this study was to assess subsequent pregnancy outcome in women with a history of stillbirth as a result of causes other than maternal conditions and fetal abnormalities.
METHODS: Ninety-two deliveries after stillbirth were identified among 11,910 deliveries of parous women recorded in the birth registry at Kuopio, Finland. Using logistic regression, pregnancy outcome measures were compared with those of a parous healthy obstetric population (n = 11,818).
RESULTS: Women with a history of stillbirth as a result of causes other than maternal conditions and fetal abnormalities were older than their unaffected controls (32.4 yr vs 30.3 yr). Stillbirth in an earlier pregnancy was associated with a significantly higher (p < 0.001) frequency of placental abruption in subsequent pregnancy (5.4% vs 0.7%). A history of stillbirth was predictive of preterm delivery (OR = 2.25) and low-birthweight infants (OR = 2.70). No recurrence was reported.
CONCLUSIONS: Pregnancy with a history of stillbirth as a result of causes other than maternal conditions and fetal abnormalities is a moderate risk state, with prematurity and low-birthweight rates somewhat higher than those in the general population. The overall probability of a favorable outcome is good. These findings may be useful in counseling pregnant women with a history of stillbirth.

Entities:  

Mesh:

Year:  2000        PMID: 10865558     DOI: 10.1046/j.1523-536x.2000.00033.x

Source DB:  PubMed          Journal:  Birth        ISSN: 0730-7659            Impact factor:   3.689


  7 in total

1.  Malaria, intestinal helminths and other risk factors for stillbirth in Ghana.

Authors:  Nelly J Yatich; Ellen Funkhouser; John E Ehiri; Tsiri Agbenyega; Jonathan K Stiles; Julian C Rayner; Archer Turpin; William O Ellis; Yi Jiang; Jonathan H Williams; Evans Afriyie-Gwayu; Timothy Phillips; Pauline E Jolly
Journal:  Infect Dis Obstet Gynecol       Date:  2010-04-01

Review 2.  Is segregation bad for your health?

Authors:  Michael R Kramer; Carol R Hogue
Journal:  Epidemiol Rev       Date:  2009-05-23       Impact factor: 6.222

3.  Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.

Authors:  Aleena M Wojcieszek; Emily Shepherd; Philippa Middleton; Zohra S Lassi; Trish Wilson; Margaret M Murphy; Alexander Ep Heazell; David A Ellwood; Robert M Silver; Vicki Flenady
Journal:  Cochrane Database Syst Rev       Date:  2018-12-17

4.  [Frequency and Maternals risk factors of fœtal intra uterin death at Kamina, Democratic Republic of Congo].

Authors:  Ignace Bwana Kangulu; Albert Mwembo Tambwe A'Nkoy; John Ngoy Lumbule; Elie Kilolo Ngoy Umba; Michel Kabamba Nzaji; Prosper Kalenga Muenze Kayamba
Journal:  Pan Afr Med J       Date:  2016-03-17

5.  Research priorities and potential methodologies to inform care in subsequent pregnancies following stillbirth: a web-based survey of healthcare professionals, researchers and advocates.

Authors:  Aleena M Wojcieszek; Alexander Ep Heazell; Philippa Middleton; David Ellwood; Robert M Silver; Vicki Flenady
Journal:  BMJ Open       Date:  2019-06-22       Impact factor: 2.692

6.  Adverse Perinatal Outcome in Subsequent Pregnancy after Stillbirth by Placental Vascular Disorders.

Authors:  Francesca Monari; Giulia Pedrielli; Patrizia Vergani; Elisa Pozzi; Federico Mecacci; Caterina Serena; Isabella Neri; Fabio Facchinetti
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

7.  Predicting singleton antepartum stillbirth by the demographic Fetal Medicine Foundation Risk Calculator-A retrospective case-control study.

Authors:  Dana A Muin; Karin Windsperger; Nadia Attia; Herbert Kiss
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.